On 26 February, ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) announced Net loss for the fourth quarter of 2014 was $10.4 million, or $(0.09) per share, compared to a net loss of $8.9 million, or $(0.09) per share, for the fourth quarter of 2013. On Monday shares of ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) closed at $11.79.
On 23 February, Arrowhead Research Corporation (NASDAQ: ARWR), announced that it has initiated dosing in a Phase 1 clinical trial of ARC-AAT, the company’s candidate for the treatment of liver disease associated with Alpha-1 Antitrypsin Deficiency (AATD), a rare genetic disorder that severely damages the liver and lungs of affected individuals. Arrowhead Research Corp. (NASDAQ:ARWR) in last trading activity fell -2.79% to close at $7.32. Company weekly performance is -6.51% while its quarterly performance stands at 26.64%. Arrowhead Research Corp. (NASDAQ:ARWR) is -73.51% away from its 52 week high.
JDSU Uniphase Corporation (NASDAQ: JDSU) announced a series of mobile-carrier portfolio enhancements designed to support flawless subscriber experiences through improved service delivery, performance monitoring and troubleshooting across the network. On last trading day JDS Uniphase Corporation (NASDAQ:JDSU) increased 0.29% to close at $13.81. Its volatility for the week is 2.17% while volatility for the month is 2.89%. JDSU’s sales growth for past 5 years was 6.30% and its EPS growth for past 5 years was 54.70%. JDS Uniphase Corporation (NASDAQ:JDSU) monthly performance is 4.15%.
TheStreet cut shares of Digimarc Corp (NASDAQ:DMRC) from a hold rating to a sell rating in a research report sent to investors on Thursday morning. Digimarc Corporation (NASDAQ:DMRC) has 3.40% insider ownership while its institutional ownership stands at 47.80%. In last trading activity company’s stock closed at $25.16.
On last trading day BRF S.A. (NYSE:BRFS) fell -2.47% to close at $22.14. Its volatility for the week is 2.13% while volatility for the month is 1.87%. BRFS’s sales growth for past 5 years was 21.80% and its EPS growth for past 5 years was 66.40%. BRF S.A. (NYSE:BRFS) monthly performance is -8.29%.